Skip to main content

Want a detailed portfolio tracker?

Atrium Therapeutics (RNA) Revenue (2025 - 2026)

Atrium Therapeutics (RNA) revenue from Mar 31, 2025 to Mar 31, 2026. The TTM Atrium Therapeutics (RNA) revenue is $20M. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Quarterly Revenue

Atrium Therapeutics (RNA) Revenue CAGR table

PeriodCAGR
1 Year+1150.96%

Annual Revenue change of Atrium Therapeutics (RNA)

YearRevenueChange
2026$20M+1150.96%
2025$1.57MN/A